Skip to main content

Janney Buys Into KemPharm Ahead Of 'Transformative' Summer Catalyst

By: via Benzinga
KemPharm Inc (NASDAQ: KMPH) has struggled to gain traction since its 2015 initial public offering, but one long-sidelined analyst is ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.